髌下脂肪垫间充质基质细胞来源外泌体加速前交叉韧带重建术后腱骨愈合与关节内移植物重塑
一项在大鼠前交叉韧带重建(ACLR)模型中开展的对照实验室研究,将90只雄性Sprague Dawley大鼠随机分为假注射组、对照注射组和髌下脂肪垫(IPFP)间充质基质细胞(MSC)来源外泌体注射组。结果显示,外泌体注射组在术后4周和8周的失败载荷与刚度显著高于其他两组,并促进腱骨界面纤维软骨形成、新骨长入及关节内移植物重塑,同时减少促炎M1巨噬细胞、增加修复性M2巨噬细胞。作者认为该无细胞疗法可能通过免疫调节巨噬细胞极化发挥作用,或可作为改善ACLR术后愈合的治疗选择。
要点
- 在大鼠ACLR模型中,IPFP MSC来源外泌体注射组术后4周和8周的失败载荷与刚度显著高于假注射组和对照注射组。
- 外泌体注射组腱骨愈合界面更薄且纤维软骨更多,骨隧道平均面积更小、骨体积/总体积比更大,关节内移植物细胞浸润更多且8周时纤维排列更规则、胶原更成熟。
- 外泌体注射组腱骨界面和关节内移植物的促炎M1巨噬细胞显著少于其他两组,修复性M2巨噬细胞显著多于其他两组。
核心结论
- IPFP MSC来源外泌体加速了大鼠ACLR术后的腱骨愈合和关节内移植物重塑,可能源于对巨噬细胞极化的免疫调节。
- 作者认为,IPFP来源MSC外泌体作为一种新兴的无细胞方法,可能成为改善ACLR术后腱骨愈合和关节内移植物重塑的治疗选择。
研究设计与样本
- 受控实验室研究,共90只骨骼成熟雄性Sprague Dawley大鼠行单侧ACLR并采用自体移植物。
- 大鼠随机分为3组:假注射组(n=30)、对照注射组(n=30)和IPFP MSC来源外泌体注射组(n=30)。
- 术后2、4、8周通过生物力学测试、微型CT和组织学分析评估腱骨愈合与关节内移植物重塑,并用免疫组化染色评估巨噬细胞极化。
主要发现
- 生物力学测试显示,术后4周和8周IPFP MSC来源外泌体注射组的失败载荷和刚度显著高于假注射组和对照注射组。
- 术后4周和8周,外泌体注射组腱骨愈合界面更薄且纤维软骨更多。
- 微型CT显示外泌体注射组新骨长入多于其他组,表现为平均骨隧道面积更小和骨体积/总体积比更大。
- 术后4周外泌体注射组关节内移植物细胞浸润多于其他组,术后8周纤维排列更规则且胶原更成熟。
- 外泌体注射组腱骨界面和关节内移植物的促炎M1巨噬细胞显著少于假注射组和对照注射组,修复性M2巨噬细胞显著多于假注射组和对照注射组。
临床怎么用
- 作者认为,IPFP可由大多数骨科医生容易地获取;IPFP MSC来源外泌体作为一种新兴的无细胞方法,可能成为改善ACLR术后腱骨愈合和关节内移植物重塑的治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exosomes derived from mesenchymal stromal cells (MSCs) reportedly enhance the healing process. However, no studies have investigated the effect of exosomes from infrapatellar fat pad (IPFP) MSCs on tendon-bone healing and intra-articular graft remodeling after anterior cruciate ligament reconstruction (ACLR). PURPOSE: To evaluate the in vivo effect of exosomes from IPFP MSCs on tendon-bone healing and intra-articular graft remodeling in a rat model of ACLR. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 90 skeletally mature male Sprague Dawley rats underwent unilateral ACLR using an autograft. All rats were randomly divided into 3 groups: sham injection (SI) group (n = 30), control injection (CI) group (n = 30), and IPFP MSC-derived exosome injection (IMEI) group (n = 30). At 2, 4, and 8 weeks postoperatively, tendon-bone healing and intra-articular graft remodeling were evaluated via biomechanical testing, micro-computed tomography, and histological analysis; macrophage polarization was evaluated using immunohistochemical staining. RESULTS: Biomechanical testing demonstrated a significantly higher failure load and stiffness in the IMEI group than in the SI and CI groups at 4 and 8 weeks postoperatively. Moreover, a thinner graft-to-bone healing interface with more fibrocartilage was observed in the IMEI group at both time points. Micro-computed tomography revealed greater new bone ingrowth in the IMEI group than in the other groups, as demonstrated by smaller mean bone tunnel areas and a larger bone volume/total volume ratio. Additionally, more cellular infiltration was observed in the intra-articular graft in the IMEI group than in the other groups at 4 weeks, followed by more regularly organized fibers with mature collagen at 8 weeks. Notably, similar trends of macrophage polarization were found at both the graft-to-bone interface and the intra-articular graft in the IMEI group, with significantly fewer proinflammatory M1 macrophages and larger numbers of reparative M2 macrophages than in the SI and CI groups. CONCLUSION: IPFP MSC-derived exosomes accelerated tendon-bone healing and intra-articular graft remodeling after ACLR, which may have resulted from the immunomodulation of macrophage polarization. CLINICAL RELEVANCE: The IPFP can be easily harvested by most orthopaedic surgeons. Exosomes from IPFP MSCs, constituting a newly emerging cell-free approach, may represent a treatment option for improving tendon-bone healing and intra-articular graft remodeling after ACLR.
引用
- Xu J, Ye Z, Han K, et al. Infrapatellar Fat Pad Mesenchymal Stromal Cell-Derived Exosomes Accelerate Tendon-Bone Healing and Intra-articular Graft Remodeling After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2022. PMID: 35224997. doi:10.1177/03635465211072227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。